Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology INDIANAPOLIS and SOUTH SAN FRANCISCO, Calif., June 20, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and DICE Therapeutics, Inc. (NASDAQ: DICE) today announced a definitive agreement...
Arvinas Announces Interim Data from the ARV-766 Phase 1/2 Dose Escalation and Expansion Trial Showing Promising Signals of Efficacy in Late-line mCRPC, Including in Patients with AR L702H Mutations – 42% of patients with AR ligand binding domain (LBD) mutations...
COGENT BIOSCIENCES ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING OF SHARES OF COMMON STOCK WALTHAM, Mass. and BOULDER, Colo., June 06, 2023 (GLOBE NEWSWIRE) — Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision...
COGENT BIOSCIENCES ANNOUNCES POSITIVE LEAD-IN DATA FROM ONGOING PHASE 3 PEAK TRIAL EVALUATING BEZUCLASTINIB IN COMBINATION WITH SUNITINIB IN PATIENTS WITH GASTROINTESTINAL STROMAL TUMORS (GIST) – Data presented at ASCO annual meeting demonstrate 55% Disease...
Cleerly Partners with ProScan Imaging to Transform the Standard of Care for Heart Disease PreventionProScan’s imaging centers in two major regions will now leverage Cleerly’s AI-enabled approach to develop personalized heart care diagnoses and treatment plans DENVER –...
Recent Comments